Golden Retriever Lifetime Study Data & Samples supports researchers with biological samples and owner- and veterinarian-reported data to investigate cancer and other major diseases in dogs.
The rolling data and samples RFP, previously listed as open January 12, 2026, is temporarily closed as of November 9, 2026. The academic application link was removed; industry partnership requests remain available.
Funder: Morris Animal Foundation
Due Dates: Rolling (applications accepted throughout the calendar year)
Funding Amounts: Data and biospecimen access only; no financial funding
Summary: Supports canine health research through access to lifetime biological samples and owner- and veterinarian-reported data.
Key Information: Applicants must coordinate resource availability with the data team before submission and demonstrate funding for processing.
Morris Animal Foundation’s Golden Retriever Lifetime Study provides researchers with annually collected biological samples and owner- and veterinarian-reported data from privately owned dogs across the lower 48 United States. Its primary goal is to identify the incidence of and risk factors for osteosarcoma, hemangiosarcoma, lymphoma and high-grade mast cell tumors.
Secondary research goals include other cancers and major diseases such as hypothyroidism, epilepsy, allergy disorders, hip dysplasia, congestive heart failure and renal failure. Through the Bette M. Morris Data Commons & Biorepository, researchers from academia, nonprofit organizations and industry may request resources to investigate critical questions in canine health. The Foundation is particularly interested in collaborative projects that leverage the study’s longitudinal design.